To evaluate the diagnostic specificity of altered PLCB1 levels and the effect of suicide status, we also measured PLCB1 protein in BA9 from subjects with major depressive disorder (MDD), bipolar disorder (BD), suicide completers with no history of psychiatric illness, and matched non-psychiatric, non-suicide controls (cohort 2). Here, PLCB1 is linked to major depressive disorder.